TMPRSS2 and COVID-19: Since higher TMPRSS2 levels seemed to be a possible determinant for COVID-19 symptoms in the present study, the usage of protease blockers would show itself to be appealing, although not knowing TMPRSS2 ́s role in human physiology could be a risk.